Cardiovascular effects of lovastatin in normotensive and spontaneously hypertensive rats

General Pharmacology

Volumn 30, Issue 3, 1998, Pages 331-336

  Bravo, L ^a   Herrera, M D ^a   Marhuenda, E ^a   Perez Guerrero, C ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Blood pressure; Lovastatin; Rat aorta; SHRs

Indexed keywords

CALCIUM CHANNEL; FUROSEMIDE; MEVINOLIN; NIFEDIPINE; NORADRENALIN; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIURESIS; DRUG EFFECT; HEART RATE; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; DEPRESSION, CHEMICAL; HEART RATE; LOVASTATIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 0032033295     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00312-6     Document Type: Article

References (28)

1. Alberts A. W., MacDonald J. S., Till A. E., Tobert J. A. Lovastatin. Cardiovasc. Drug Rev. 7:1989;89-109.
2. Ames R. P. Hyperlipidemia in hypertension. Causes and prevention Am. Heart J. 122:1991;1219-1224.
3. Aranda P., Aranda J. M., Carmona J., Nuñez D. Relaciones entre colesterol y presión arterial en el estudio Málaga 86. Algo más que una asociación casual? Rev. Clin. Esp. 187:1990;13-17.
4. Bolton T. Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59:1979;606-717.
5. Bonaa K. H., Thelle D. S. Association between blood pressure and serum lipids in a population. The Trömso Study. Circulation. 83:1991;1305-1313.
6. Bravo E. L. Metabolic factors and sympathetic nervous system. Am. J. Hypertens. 2:1989;339S-344S.
7. Castelli W. P., Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study Am. J. Med. 80(Suppl 2A):1986;23-32.
8. Ekelund L. G., MacMahon R. P., Whaley F. S., Corder E. H., Rubenstein C. L. Does lowering of cholesterol with cholestyramine decrease the incidence of hypertension in hypercholesterolemic men? The LRC coronary primary prevention trial (abstract). CVD Epidemiol. Newslett. 43:1988;13.
9. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
10. Godfraind T., Miller R., Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 38:1986;321-416.
11. Grundy S. M. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N. Engl. J. Med. 319:1988;24-33.
12. Henry P. D. Hyperlipidemic arterial dysfunction. Circulation. 81:1990;697-699.
13. Hudgins P., Weiss G. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther. 159:1964;91-98.
14. Konishi M., Su C. Roles of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 5:1983;881-886.
15. Levy B. I., Duriez M., Phillipe M., Poitevin P., Michel J. B. Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats. Circulation. 90:1994;3024-3033.
16. Lipschitz W. L., Hadidian A., Kerpcsar A. Bioassay of diuretic. J. Pharm. exp. Therap. 79:1943;97.
17. Lokette W., Otsuka Y., Carretero O. The loss of endothelium dependent vascular relaxation in hypertension. Hypertension. 8(Suppl. II):1986;61-66.
18. Lüscher T. F. Functional abnormalities of the vascular endothelium in hypertension and atheroesclerosis. Scand J. Clin. Lab. Invest. 50(suppl):1990;28-32.
19. MacMahon S. W., MacDonald G. J., Blacket R. B. Plasma lipoprotein levels in treated and untreated hypertensive men and women. Arteriosclerosis. 5:1985;391-396.
20. Osugi S., Shimamura K., Sunano S. Decreased modulation by endothelium of noradrenaline-induced contractions in aorta from stroke-prone spontaneously hypertensive rats. Arch. Int. Pharmacodyn. 305:1990;86-99.
21. Panza J. A., Quyyumi A. A., Brush J. E., Epstein S. E. Abnormal endothelium-dependent, vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323:1990;22-27.
22. Reaven G. M., Hoffman B. B. Hypertension as a disease of carbohydrate and lipoprotein metabolim. Am. J. Med. 87(Suppl 6A):1989;2-6.
23. Shirasaki Y., Kolm P., Nickols G. A., Lee T. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J. Pharmacol. Exp. Ther. 245:1988;53-58.
24. Somlyo A. P. Excitation-contraction coupling and ultrastructure of smooth muscle. Circ. Res. 57:1985;2266-2274.
25. Stamler J., Wentworth D., Neoaton J. D. Prevalence and pronostic significance of hypercholesterolemia in men with hypertension. Am. J. Med. 80(Suppl 2A):1986;33-36.
26. Sunano S., Osugi O., Shimamura K. Blood pressure and impairment of endothelium-dependent relaxation in spontaneously hypertensive rats. Experientia. 45:1989;705-708.
27. Taira N. Differences in cardiovascular profile among calcium antagonists. Amer. J. Cardiol. 59:1987;24B-29B.
28. Winquist R. J. Bunting P. B., Baskin E. P., Wallace A. A. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J. Hypert. 2:1984;541-545.